TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo

TURK İLAÇ VE SERUM SANAYİ A.Ş.

Develops and manufactures IV solutions, vaccines, and other human medical products.

TRILC | IS

Overview

Corporate Details

ISIN(s):
TRETRLC00014 (+1 more)
LEI:
78900003BNEUMO8X3Y93
Country:
Türkiye
Address:
BÜĞDÜZ MAH. ENVER PAŞA CAD. NO: 8 AKYURT / ANKARA, 06750 ANKARA

Description

TURK İLAÇ VE SERUM SANAYİ A.Ş. is a pharmaceutical company engaged in the development, manufacturing, and sale of human medical products. The company's core business revolves around the production of IV Parenteral Solutions (serum), operating a high-capacity manufacturing facility that establishes it as a major supplier. In addition to serum, its portfolio includes a variety of other essential pharmaceuticals such as vaccines, ampoules, vials, and tablets. The company has also established a significant presence in biotechnology with the development of an integrated vaccine production facility.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-01 09:13
Aversi LLC Yeni iş ilişkisi
Turkish 33.8 KB
2025-11-19 08:47
2025-9 Aylık IMS (IQVIA) resmi verilerinde ürünlerimizin Türkiye Pazarındaki Ku…
Turkish 17.7 KB
2025-11-18 12:36
Emkan Global İle İmzalanan Yetkili Satıcılık Sözleşmesi Hakkında
Turkish 33.8 KB
2025-10-30 16:20
2024 Yılı TSRS Uyumlu Sürdürülebilirlik Raporu
Turkish 1.7 MB
2025-10-30 16:20
2024 Yılı TSRS Uyumlu Sürdürülebilirlik Raporu
Turkish 15.2 KB
2025-10-30 16:19
Sorumluluk Beyanı
Turkish 20.4 KB
2025-10-30 16:19
2025 3 dönem Faaliyet Raporu
Turkish 2.1 MB
2025-10-30 16:19
2025 3 dönem Faaliyet Raporu
English 10.9 KB
2025-10-30 16:18
Financial Report
Turkish 1.7 MB
2025-10-30 16:18
Financial Report
English 2.5 MB
2025-10-28 17:23
Sürdürülebilirlik Komitesi Üye Seçimi
Turkish 17.4 KB
2025-10-07 13:01
DMO İhale Sonucu Hakkında
English 42.1 KB
2025-10-07 12:49
DMO İhale Sonucu Hakkında
English 42.6 KB
2025-09-29 14:13
Finansman Bonosu İtfası Hakkında
English 15.2 KB
2025-09-29 07:01
Satışın Tamamlanması Hakkında
English 18.2 KB

Automate Your Workflow. Get a real-time feed of all TURK İLAÇ VE SERUM SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TURK İLAÇ VE SERUM SANAYİ A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TURK İLAÇ VE SERUM SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BELITE BIO, INC Logo
Clinical-stage biopharma developing therapies for retinal and metabolic diseases.
United States of America
BLTE
Benitec Biopharma Inc. Logo
A clinical-stage biotech developing genetic medicines to silence disease-causing genes.
United States of America
BNTC
BeOne Medicines Ltd. Logo
Global oncology company that discovers, develops, and delivers cancer treatments.
United States of America
ONC
BerGenBio Logo
Clinical-stage biopharma that developed selective AXL kinase inhibitors for cancer.
Norway
BGBIO
Beximco Pharmaceuticals Ltd. Logo
Manufacturer of generic drugs, APIs, and specialized products for global markets.
Bangladesh
BXP
BeyondSpring Inc. Logo
Clinical-stage biopharma company developing immuno-oncology cancer therapies.
United States of America
BYSI
BGM Group Ltd. Logo
A holding company focused on technology and biopharmaceutical manufacturing.
United States of America
BGM
Bicara Therapeutics Inc. Logo
Clinical-stage biopharma developing dual-action biologics for solid tumors.
United States of America
BCAX
BICYCLE THERAPEUTICS PLC Logo
Clinical-stage biopharma developing a novel class of bicyclic peptide medicines.
United States of America
BCYC
BIFIDO. Co. Ltd Logo
Biotechnology firm developing human-derived Bifidobacterium for various products.
South Korea
238200

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.